Oral anticoagulation in device-detected atrial fibrillation: effects of age, sex, cardiovascular comorbidities, and kidney function on outcomes in the NOAH-AFNET 6 trial.

Autor: Lip, Gregory Y H, Nikorowitsch, Julius, Sehner, Susanne, Becher, Nina, Bertaglia, Emanuele, Blomstrom-Lundqvist, Carina, Brandes, Axel, Beuger, Vincent, Calvert, Melanie, Camm, A John, Chlouverakis, Gregory, Dan, Gheorghe-Andrei, Dichtl, Wolfgang, Diener, Hans Christoph, Fierenz, Alexander, Goette, Andreas, Groot, Joris R de, Hermans, Astrid, Lubinski, Andrzej, Marijon, Eloi
Předmět:
Zdroj: European Heart Journal; 5/14/2024, Vol. 45 Issue 19, p1733-1737, 5p
Abstrakt: The article discusses the findings of a study on the effects of oral anticoagulation in patients with device-detected atrial fibrillation (DDAF) without ECG-documented atrial fibrillation (AF). The study analyzed data from 2534 patients and compared outcomes and the effect of anticoagulation in patients with different risk factors. The results showed that anticoagulation did not appear to be more effective in patients with a high risk score, and the rate of stroke was low in patients without anticoagulation. The study suggests the need for new methods to identify high-risk patients who may benefit from anticoagulation. The article also provides information about financial disclosures and funding sources related to the authors of the study. [Extracted from the article]
Databáze: Complementary Index